Replimune

-$1.06 (-2.86%) Today
$0.00 (0.00%) As of 9:15 PM UTC after-hours

Why Robinhood?

You can buy or sell Replimune and other stocks, options, and ETFs commission-free!

About REPL

Replimune Group, Inc. Common Stock, also called Replimune, is a clinical-stage biotechnology company, which engages in the development of oncolytic immunotherapy product candidates through immulytic platform.

CEO
Philip Astley-Sparke
Employees
122
Headquarters
Woburn, Massachusetts
Founded
2015

REPL Key Statistics

Market Cap
1.77B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
434.98K
High Today
$37.77
Low Today
$35.44
Open Price
$36.47
Volume
172.72K
52 Week High
$54.85
52 Week Low
$17.50

REPL Earnings

-$0.46
-$0.31
-$0.15
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Jun 3, Pre-Market

You May Also Like

SKY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure